CA948992A - Anti-bacterial composition containing nalidixic acid and rifampicin - Google Patents
Anti-bacterial composition containing nalidixic acid and rifampicinInfo
- Publication number
- CA948992A CA948992A CA084,360A CA84360A CA948992A CA 948992 A CA948992 A CA 948992A CA 84360 A CA84360 A CA 84360A CA 948992 A CA948992 A CA 948992A
- Authority
- CA
- Canada
- Prior art keywords
- rifampicin
- composition containing
- nalidixic acid
- bacterial composition
- containing nalidixic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- MHWLWQUZZRMNGJ-UHFFFAOYSA-N nalidixic acid Chemical compound C1=C(C)N=C2N(CC)C=C(C(O)=O)C(=O)C2=C1 MHWLWQUZZRMNGJ-UHFFFAOYSA-N 0.000 title 1
- 229960000210 nalidixic acid Drugs 0.000 title 1
- JQXXHWHPUNPDRT-WLSIYKJHSA-N rifampicin Chemical compound O([C@](C1=O)(C)O/C=C/[C@@H]([C@H]([C@@H](OC(C)=O)[C@H](C)[C@H](O)[C@H](C)[C@@H](O)[C@@H](C)\C=C\C=C(C)/C(=O)NC=2C(O)=C3C([O-])=C4C)C)OC)C4=C1C3=C(O)C=2\C=N\N1CC[NH+](C)CC1 JQXXHWHPUNPDRT-WLSIYKJHSA-N 0.000 title 1
- 229960001225 rifampicin Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4323069 | 1969-06-04 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA948992A true CA948992A (en) | 1974-06-11 |
Family
ID=12658094
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA084,360A Expired CA948992A (en) | 1969-06-04 | 1970-06-02 | Anti-bacterial composition containing nalidixic acid and rifampicin |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3705243A (fr) |
| BE (1) | BE751387A (fr) |
| CA (1) | CA948992A (fr) |
| DE (1) | DE2027528A1 (fr) |
| FR (1) | FR2052931B1 (fr) |
| GB (1) | GB1276588A (fr) |
| NL (1) | NL164201C (fr) |
| ZA (1) | ZA703732B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH642850A5 (it) * | 1978-10-20 | 1984-05-15 | Ausonia Farma Srl | Composizioni farmaceutiche ad attivita antibatterica contro infezioni da germi gram-positivi e gram-negativi. |
| AT386951B (de) * | 1979-04-26 | 1988-11-10 | Bristol Myers Co | Verfahren zur herstellung von antibakteriellen mischungen |
-
1970
- 1970-06-02 CA CA084,360A patent/CA948992A/en not_active Expired
- 1970-06-02 ZA ZA703732A patent/ZA703732B/xx unknown
- 1970-06-03 GB GB26799/70A patent/GB1276588A/en not_active Expired
- 1970-06-03 BE BE751387D patent/BE751387A/fr unknown
- 1970-06-03 NL NL7008044.A patent/NL164201C/xx not_active IP Right Cessation
- 1970-06-04 FR FR707020571A patent/FR2052931B1/fr not_active Expired
- 1970-06-04 DE DE19702027528 patent/DE2027528A1/de not_active Withdrawn
- 1970-06-04 US US43396A patent/US3705243A/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| DE2027528A1 (de) | 1970-12-10 |
| BE751387A (fr) | 1970-11-16 |
| FR2052931B1 (fr) | 1974-06-14 |
| FR2052931A1 (fr) | 1971-04-16 |
| NL164201C (nl) | 1980-12-15 |
| ZA703732B (en) | 1971-01-27 |
| NL164201B (nl) | 1980-07-15 |
| GB1276588A (en) | 1972-06-01 |
| NL7008044A (fr) | 1970-12-08 |
| US3705243A (en) | 1972-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA949451A (en) | Antiseptic composition | |
| AU1239270A (en) | Descaling composition | |
| CA926546A (en) | Anaerobic composition | |
| AU1605470A (en) | Film-forming composition | |
| CA928218A (en) | Antiinfectious compositions and process for their preparation | |
| CA924988A (en) | Depurative process and composition | |
| AU2315470A (en) | Chemical composition | |
| CA923425A (en) | Compositions containing garcinia acid | |
| AU2383770A (en) | Compounds | |
| AU1211470A (en) | Composition | |
| AU2315270A (en) | Chemical composition | |
| AU456939B2 (en) | Ester containing composition | |
| AU448191B2 (en) | Stabilized composition | |
| AU448844B2 (en) | Composition | |
| AU442073B2 (en) | Antiseptic composition | |
| AU449360B2 (en) | Stabilizing composition | |
| AU453959B2 (en) | Hydroxycitric acid derivatives containing compositions | |
| AU415155B2 (en) | Ultrafiltration of electro-depositable compositions | |
| AU443007B2 (en) | Gibberellic acid composition | |
| CA824577A (en) | Azeotropic composition | |
| AU1484670A (en) | Ester containing composition | |
| CA825607A (en) | Ferromagnetic-semiconductor composition | |
| CA817476A (en) | Methylvinylpolysiloxane-silica composition | |
| CA815573A (en) | Polydiolefin polysilyl composition | |
| AU4960269A (en) | Composition of matter |